Kristoffer Strålin

Dr. Kristoffer Strålin

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2020 in Science Immunology
Verified
Journal Article
Open access
PDF file
CMChristopher Maucourant
Christopher Maucourant
IFIva Filipovic
Iva Filipovic
APAndrea Ponzetta
Andrea Ponzetta
SASoo Aleman
Soo Aleman
MCMartin Cornillet
Martin Cornillet
NBNiklas Björkström
Niklas Björkström
Understanding innate immune responses in COVID-19 is important to decipher mechanisms of host responses and interpret disease pathogenesis. Natural killer (NK) cells are innate effector lymphocytes that respond to acute viral infections but might also contribute to immunopathology. Using 28-color flow cytometry, we here reveal strong NK cell activation across distinct subsets in peripheral blood of COVID-19 patients. This pattern was mirrored in scRNA-seq signatures of NK cells in bronchoalveolar lavage from COVID-19 patients. Unsupervised high-dimensional analysis of peripheral blood NK cells furthermore identified distinct NK cell immunotypes that were linked to disease severity. Hallmarks of these immunotypes were high expression of perforin, NKG2C, and Ksp37, reflecting increased presence of adaptive NK cells in circulation of patients with severe disease. Finally, arming of CD56bright NK cells was observed across COVID-19 disease states, driven by a defined protein-protein interaction network of inflammatory soluble factors. This study provides a detailed map of the NK cell activation landscape in COVID-19 disease.

18 September 2020 in Science Immunology
Verified
Journal Article
Open access
PDF file
TPTiphaine Parrot
Tiphaine Parrot
JGJean-Baptiste Gorin
Jean-Baptiste Gorin
APAndrea Ponzetta
Andrea Ponzetta
KMKimia T. Maleki
Kimia T. Maleki
TKTobias Kammann
Tobias Kammann
JSJohan Sandberg
Johan Sandberg
Severe COVID-19 is characterized by excessive inflammation of the lower airways. The balance of protective versus pathological immune responses in COVID-19 is incompletely understood. Mucosa-associated invariant T (MAIT) cells are antimicrobial T cells that recognize bacterial metabolites, and can also function as innate-like sensors and mediators of antiviral responses. Here, we investigated the MAIT cell compartment in COVID-19 patients with moderate and severe disease, as well as in convalescence. We show profound and preferential decline in MAIT cells in the circulation of patients with active disease paired with strong activation. Furthermore, transcriptomic analyses indicated significant MAIT cell enrichment and pro-inflammatory IL-17A bias in the airways. Unsupervised analysis identified MAIT cell CD69high and CXCR3low immunotypes associated with poor clinical outcome. MAIT cell levels normalized in the convalescent phase, consistent with dynamic recruitment to the tissues and later release back into the circulation when disease is resolved. These findings indicate that MAIT cells are engaged in the immune response against SARS-CoV-2 and suggest their possible involvement in COVID-19 immunopathogenesis.

29 June 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
TSTakuya Sekine
Takuya Sekine
APAndré Perez-Potti
André Perez-Potti
OROlga Rivera-Ballesteros
Olga Rivera-Ballesteros
KSKristoffer Strålin
Kristoffer Strålin
JGJean-Baptiste Gorin
Jean-Baptiste Gorin
MBMarcus Buggert
Marcus Buggert
SARS-CoV-2-specific memory T cells will likely prove critical for long-term immune protection against COVID-19. We systematically mapped the functional and phenotypic landscape of SARS-CoV-2-specific T cell responses in a large cohort of unexposed individuals as well as exposed family members and individuals with acute or convalescent COVID-19. Acute phase SARS-CoV-2-specific T cells displayed a highly activated cytotoxic phenotype that correlated with various clinical markers of disease severity, whereas convalescent phase SARS-CoV-2-specific T cells were polyfunctional and displayed a stem-like memory phenotype. Importantly, SARS-CoV-2-specific T cells were detectable in antibody-seronegative family members and individuals with a history of asymptomatic or mild COVID-19. Our collective dataset shows that SARS-CoV-2 elicits robust memory T cell responses akin to those observed in the context of successful vaccines, suggesting that natural exposure or infection may prevent recurrent episodes of severe COVID-19 also in seronegative individuals.

21 September 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MLMagda Lourda
Magda Lourda
MDMajda Dzidic
Majda Dzidic
LHLaura Hertwig
Laura Hertwig
HBHelena Bergsten
Helena Bergsten
LMLaura M. Palma Medina
Laura M. Palma Medina
KGKarolinska KI/K COVID-19 Study Group
Karolinska KI/K COVID-19 Study Group
Significance: Accumulating evidence shows that granulocytes are key modulators of the immune response to SARS-CoV-2 infection, and their dysregulation could significantly impact COVID-19 severity and patient recovery after virus clearance. In the present study, we identify selected immune traits in neutrophil, eosinophil, and basophil subsets associated with severity of COVID-19 and with peripheral protein profiles. Moreover, computational modeling indicates that the combined use of phenotypic data and laboratory measurements can effectively predict key clinical outcomes in COVID-19 patients. Finally, patient-matched longitudinal analysis shows phenotypic normalization of granulocyte subsets 4 mo after hospitalization. Overall, in this work, we extend the current understanding of the distinct contribution of granulocyte subsets to COVID-19 pathogenesis.

18 December 2025 in Science
Verified
Journal Article
Closed access
MÁMaría Bueno Álvez
María Bueno Álvez
SBSofia Bergström
Sofia Bergström
JKJosefin Kenrick
Josefin Kenrick
EJEmil Johansson
Emil Johansson
MAMikael Aberg
Mikael Aberg
MUMathias Uhlen
Mathias Uhlen
The human blood proteome provides a holistic readout of health states through the assessment of thousands of circulating proteins. In this study, we present a pan-disease resource to enable the study of diverse disease phenotypes within a harmonized proteomics dataset. By profiling protein concentrations across 59 diseases and healthy cohorts, we identified proteins associated with age, sex, and body mass index, as well as disease-specific signatures. This study highlights shared and distinct protein patterns across conditions, demonstrating the power of a unified proteomics approach to uncover biological insights. The dataset, covering 8262 individuals and up to 5416 proteins, serves as an online resource for exploring disease-specific protein profiles and advancing precision medicine research.

22 December 2023 in Science Immunology
Verified
Journal Article
Open access
CCCurtis Cai
Curtis Cai
YGYu Gao
Yu Gao
SASarah Adamo
Sarah Adamo
OROlga Rivera-Ballesteros
Olga Rivera-Ballesteros
LHLotta Hansson
Lotta Hansson
MBMarcus Buggert
Marcus Buggert
T cells are critical for immune protection against severe COVID-19, but it has remained unclear whether repeated exposure to SARS-CoV-2 antigens delivered in the context of vaccination fuels T cell exhaustion or reshapes T cell functionality. Here, we sampled convalescent donors with a history of mild or severe COVID-19 before and after SARS-CoV-2 vaccination to profile the functional spectrum of hybrid T cell immunity. Using combined single-cell technologies and high-dimensional flow cytometry, we found that the frequencies and functional capabilities of spike-specific CD4 + and CD8 + T cells in previously infected individuals were enhanced by vaccination, despite concomitant increases in the expression of inhibitory receptors such as PD-1 and TIM3. In contrast, CD4 + and CD8 + T cells targeting non-spike proteins remained functionally static and waned over time, and only minimal effects were observed in healthy vaccinated donors experiencing breakthrough infections with SARS-CoV-2. Moreover, hybrid immunity was characterized by elevated expression of IFN-γ, which was linked with clonotype specificity in the CD8 + T cell lineage. Collectively, these findings identify a molecular hallmark of hybrid immunity and suggest that vaccination after infection is associated with cumulative immunological benefits over time, potentially conferring enhanced protection against subsequent episodes of COVID-19.